Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#618 most reported symptom for this vaccine
Gaze palsy has been reported 41 times in association with Zoster Live (Zostavax) vaccination in VAERS. This represents 0.0% of all 140,312 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 8 involved hospitalization (19.5%).
Gaze palsy is the #618 most frequently reported symptom for Zoster Live (Zostavax) out of 2827 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 41 reports of Gaze palsy after Zoster Live (Zostavax) vaccination may seem alarming, but context is critical. With 140,312 total reports for this vaccine (representing many millions of doses), Gaze palsy appears in only 0.0% of reports.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.